Abstract
Establishment of non-invasive urinary biomarker for the early prediction of essential hypertension (EH) is important. We evaluated whether estimation of urinary DNA, serves as a marker to predict the extent of cellular oxidative stress in essential hypertension. A total of 180 South Indian subjects aged 30–65 were recruited for the study. Of these hypertensive subjects investigated, 30 were newly diagnosed and were not on any antihypertensive drugs, but had systolic blood pressure 140–160 mmHg and diastolic blood pressure 95–100 mmHg and 75 hypertensive patients who already on drug therapy for one year and 75 were South Indian normotensive healthy controls with blood pressure ≤ 120/80 mmHg. The 8-OHdG level in urine was significantly increased in hypertensive patients (both newly diagnosed and who already on drug therapy) compared with control group. The significant increase in 8-OHdG was observed in newly diagnosed hypertensive patients compared with hypertensive patients who already on drug therapy. There was a significant decrease in serum TAS value in essential hypertensive group when compared to control group. The urinary 8-OHdG was independently correlated with serum TAS. Decreased TAS levels, which reflect to increased oxidative stress, may be the reason of increased urinary 8-OHdG in South Indian hypertensive patients. Our preliminary data suggest that the competitive ELISA for 8-OHdG appears to be a simple method for quantifying the extent of oxidative stress.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 report. JAMA 2003; 289: 2560–2572.
Cooke MS, Evans MD, Burd RM, Patel K, Barnard A, Lunec J. Induction and excretion of ultraviolet-induced 8-oxo-2′-deoxyguanosine and thymine dimers in vivo: implications for PUVA. J Invest Dermatol 2001; 116:281–285.
Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. Oxford Univ. Press 1999; 3rd ed: OX2 6DP.
Trzeciak AR, Nyaga SG, Jaruga P, Lohani A, Dizdaroglu M, Evans MK. Carcinogenesis 2004; 25: 1359–1370.
Evans MD, Dizdaroglu M, Cooke MS. Oxidative DNA damage and disease: induction, repair, and significance. Mutat Res 2004; 567: 1–61.
Chiou CC, Chang PY, Chan EC, Wu TL, Tsao KC, Wu JT. Urinary 8-hydroxy deoxy guanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder & prostate cancers. Clin Chim Acta 2003; 334: 87–94.
Brown RK, McBurney A, Lunec J, Kelly FJ. Oxidative damage to DNA in patients with cystic fibrosis. Free Radic Biol Med 1995; 18: 801–806.
Tsuboi H, Kouda K, Takeuchi H, Takigawa M, Masamoto Y, Takeuchi M, Ochi H. 8-hydoxy guanosine in urine as an index of oxidative damage to DNA in the evaluation of atopic dermatitis. Br J Dermatol 1998; 138: 1033–1035.
Rall LC, Roubenoff R, Meydani SN, Han SN, Meydani MJ. Urinary 8-hydroxy -2′-deoxy guanosine (8-OHdG) as a marker of oxidative stress in rheumatoid arthritis and aging: effect of progressive resistance training. Nutr Biochem 2000; 11: 581–584.
Iris EF Benzie. Ferric reducing antioxidant power assay. Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods of Enzymology 1996; 299: 15–27.
Erdogan C. The evaluation of oxidative stress in patients with CRF. CCA 2002; 322: 157–167.
Iris Benzie EF. The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power. The FRAP assay. Analytical Biochem 1996; 239: 70–76.
Azad N, Rojanasakul Y, Vallyathan V. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev 2008; 11: 1–15.
Hwang ES, Kim GH. Biomarkers of Oxidative stress status of DNA, lipids and proteins in vitro and in vivo cancer research. Toxicol 2007; 229: 1–10.
Bonde P, Gao D, Chen L. Selective decrease in the DNA base excision repair pathway in squamous cell cancer of the esophagus. J Thorac Cardiovasc Surg 2007; 133: 74–81.
Chen X, Ding YW, Yang G. Oxidative damage in an esophageal adenocarcinoma model with rats. Carcinogenesis 2000; 21: 257–263.
Ross R. Atherosclerosis: an inflammatory disease. N Eng J Med 1999; 340: 115–126.
Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999; 48: 1–9.
Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T. Oxidative damage to DNA in diabetes mellitus. Lancet 1996; 347: 444–445.
Chen LY, Nichols WW, Hendricks J, Mehta JL. Myocardial neutrophil infiltration, lipid peroxidation, and antioxidant activity after coronary artery thrombosis and thrombolysis. Am Heart J 1995; 129: 211–218.
Honda M, Yamada Y, Tomonaga M, Ichinose H, Kamihira S. Correlation of urinary 8-hydroxy-2-de-oxyguanosine (8-OHdG), a biomarker of oxidative DNA damage and clinical features of hematological disorders: a pilot study. Leuk Res 2000; 24: 461–468.
Tagami M, Yamagata K, Fujino H, Nara Y, Nakagawa K, Kubota A, Numano F, Yamori Y. Genetic vulnerability of cortical neurons isolated from stroke-prone spontaneously hypertensive rats in hypoxia and oxygen reperfusion. Hypertens Res 1999; 22: 23–29.
Lacy F, Connor D, Schmid-Schenbein G. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens 1998; 16: 291–303.
Russo C, Olivieri O, Girelli D, Faccini G, Zennari LM, Lombardi S, Corrocher R. Antioxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 1998; 16: 1267–1271.
Burney S, Niles JC, Dedon PC, Tannenbaum SR. DNA damage in deoxynucleosides and oligonucleotides treated with peroxynitirite. Chem Res Toxicol 1999; 12: 513–520.
Kanuchi M, Nishioka H, Hashimoto T. Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron 2002; 91: 327–329.
Harman SM, Liang L, Tsitouras Pd, Gucciardo F, Heward CB, Reaven PD, Ping W, Ahmed A, Cutler RG. Urinary excretion of three nucleic acid oxidation adducts and isoprostane F(2) alpha measured by liquid chromatography-mass spectrometry in smokers, ex-smokers and non smokers. Free Radic Biol Med 2003; 35: 1301–1309.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Subash, P., Gurumurthy, P., Sarasabharathi, A. et al. Urinary 8-OHdG: A marker of oxidative stress to DNA and total antioxidant status in essential hypertension with South Indian population. Indian J Clin Biochem 25, 127–132 (2010). https://doi.org/10.1007/s12291-010-0024-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-010-0024-z